Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Vamshi Muddu"'
Autor:
Ashok Vaid, Raja T., Ullas Batra, Vamshi Muddu Krishna, Bharath Rangrajan, Prasad Narayanan, Amish Vora, Suresh H. Advani
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 02, Pp 095-096 (2022)
Externí odkaz:
https://doaj.org/article/39d0ac8dde1b4e0baca281e180d9e52b
Autor:
Vijay Patil, Vanita Noronha, Amit Joshi, Purvish Parikh, Atanu Bhattacharjee, Santam Chakraborty, Sunny Jandyal, Vamshi Muddu, Anant Ramaswamy, K. Govinda Babu, Nilesh Lokeshwar, Sachin Hingmire, Nikhil Ghadyalpatil, Shripad Banavali, Kumar Prabhash
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 4, Pp 346-359 (2017)
Purpose: Adherence to international antiemetic prophylaxis guidelines like those of ASCO can result in better control of chemotherapy-induced nausea and vomiting; however, the extent of implementation of such guidelines in India is unknown. Therefore
Externí odkaz:
https://doaj.org/article/00928ead3a49446bbf5957a43d0af1ef
Autor:
Vijay M Patil, Vanita Noronha, Amit Joshi, Vamshi Muddu, Bharat Bhosale, Ganesh Bakshi, Kumar Prabhash
Publikováno v:
Urology Annals, Vol 6, Iss 1, Pp 18-22 (2014)
Aim: To report safety and efficacy of chemotherapy incorporating the combination of paclitaxel and platinum in patients with advanced penile carcinoma. Materials and Methods: Retrospective analysis of patient with advanced penile carcinoma undergoin
Externí odkaz:
https://doaj.org/article/9c57fe67c3484a2083adcd9aa3193318
Autor:
Vamshi Muddu, T. P. Sahoo, Bivas Biswas, Mithua Ghosh, Ashok K. Vaid, Suresh H. Advani, Ullas Batra, Anuradha Chougule, Kumar Prabhash
Publikováno v:
Advances in Therapy. 36:766-785
Novel molecular targets and promising targeted therapies have reshaped diagnostics in patients with advanced non-small cell lung cancer (NSCLC). Despite this progress, the implementation of molecular screening to identify predictive biomarkers in Ind
Autor:
Vanita Noronha, Sachin Dhumal, Kumar Prabhash, Amit Joshi, Atanu Bhattacharjee, Vamshi Muddu, Vijay Patil
Publikováno v:
Journal of Global Oncology
Purpose Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment default and non
Autor:
Anant Ramaswamy, Amit Joshi, Sunny Jandyal, Kumar Prabhash, Santam Chakraborty, Vanita Noronha, K. Govinda Babu, Sachin Hingmire, Purvish M. Parikh, Shripad Banavali, Nilesh Lokeshwar, Vijay Patil, N. Ghadyalpatil, Atanu Bhattacharjee, Vamshi Muddu
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 3, Iss 4, Pp 346-359 (2017)
Journal of Global Oncology, Vol 3, Iss 4, Pp 346-359 (2017)
Purpose Adherence to international antiemetic prophylaxis guidelines like those of ASCO can result in better control of chemotherapy-induced nausea and vomiting; however, the extent of implementation of such guidelines in India is unknown. Therefore,
Autor:
C.S. Pramesh, Ravi Thippeswamy, Kumar Prabhash, Nilendu Purandare, Vanita Noronha, Venkatesh Rangarajan, Amit Joshi, Vamshi Muddu Krishna, Sabita Jiwnani, Munita Bal
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Reporting a case, 53 years old male with stage IV Nonsamall cell lung cancer in view of cytologically proven malignant pleural effusion. Usually the management of stage IV lung cancer is with palliative intent where the patient receives palliative ch
Autor:
Supreeta Arya, Vanita Noronha, Kumar Prabhash, Atanu Bhattacharjee, Bharatsingh Bhosale, Shashikant Juvekar, Anil K. D'Cruz, Sachin Dhumal, Amit Joshi, Vamshi Muddu, Shripad Banavali, Vijay Patil
Publikováno v:
Oral oncology. 51(3)
Background Cetuximab based treatment is the recommended chemotherapy for head and neck squamous cell cancers in the palliative setting. However, due to financial constraints, intravenous (IV) chemotherapy without cetuximab is commonly used in lesser
Autor:
Pankaj Chaturvedi, Amit Joshi, V.M. Patil, Vanita Noronha, Kumar Prabhash, Devendra Chaukar, Gauri Pantvaidya, Bharatsinha Baburao Bhosale, S Juvekar, Anil K. D'Cruz, Aswari Patil, A. Dongre, Supreeta Arya, Vamshi Muddu Krishna
Publikováno v:
ISRN Oncology
This study studied the coorelation between radiological response to induction chemotherapy and acheivement of pCR or near pCR. It was a retrospective analysis in which all patients who received NACT from 2008 till april 2012 were subjected to inclusi
Autor:
Kumar Prabhash, P. S. Pai, Supreeta Arya, Vamshi Muddu, Pankaj Chaturvedi, Amit Joshi, Devendra Chaukar, S Juvekar, Vijay Patil, Anil K. D'Cruz, Sachin Dhumal, Vanita Noronha
Publikováno v:
Journal of Clinical Oncology. 32:e17033-e17033
e17033 Background: Median survival of technically unresectable oral cavity cancers (T4a and T4b) with non surgical therapy is 2-12 months. We hypothesized that neoadjuvant chemotherapy (NACT) might...